Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(67%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Completed(1)

Detailed Status

Completed1
Active, not recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
2
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

completed133%
active_not_recruiting133%
recruiting133%

Recent Activity

2 active trials
Showing 3 of 3
active_not_recruitingnot_applicable

Myocardial Injury and Outcomes Following COVID-19 Vaccination (MYOVAX Study)

NCT04967807
recruiting

PET/MR in Post Stroke Cardiac Inflammation Study

NCT05791617
completed

Respiratory Motion Correction of Cardiac Combined Positron Emission Tomography and Magnetic Resonance Imaging (PET/MRI)

NCT03200132

Clinical Trials (3)

Showing 3 of 3 trials
NCT04967807Not Applicable

Myocardial Injury and Outcomes Following COVID-19 Vaccination (MYOVAX Study)

Active Not Recruiting
NCT05791617

PET/MR in Post Stroke Cardiac Inflammation Study

Recruiting
NCT03200132

Respiratory Motion Correction of Cardiac Combined Positron Emission Tomography and Magnetic Resonance Imaging (PET/MRI)

Completed

All 3 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
3